A service from the
Financial Times
Menu
Search
Home
News & Analysis
News
Features
Opinion
Interview
Data trends
Rankings & awards
Videos
Podcast
Advertorial
Editorial Advisory Board
Research locations
Location news and data
fDi Benchmark
Reports & white papers
Promote your location
Ways to promote your location
GIS Planning solutions
Commission a video
Our GIS Planning clients
Generate leads
Find new investors
Find new customers
fDi Markets
Events
Events
Create your own event
New
Products & Services
Products & Services
New Products
Log in or register
Contact Us
Pharmaceuticals
93 results
Interview
Psychedelics move from hype to criticism phase
Tourism
Jamaica’s psychedelic ambitions: healing or trippin’?
Trade
Disruptions push Africa to the back of the queue
News
FDI round-up: Tata plans $1.58bn India gigafactory, Bosch expands in US, AstraZeneca commits to China
News
FDI round-up: Ericsson invests in Canadian R&D, US announces new EV commitments, Eli Lilly doubles down in Indiana
Advertisement
News
FDI round-up: AWS’s $8.9bn Australia pledge, Disney’s Florida spat, Bayer to invest in Ukraine
News
FDI round-up: Saudi Aramco expands in China, Eli Lilly doubles down in Limerick, Comcast’s $280m US network expansion
fDi Diaries
‘Farming is the spirit of Switzerland’
News
FDI round-up: 50Hertz pledges €8.7bn grid upgrade, Moderna chooses Oxford for UK R&D hub, Lego’s China retail expansion
News
FDI round-up: VW’s Scout plans $2bn South Carolina factory, British WANdisco seeks US tech listing, Israel’s CyberArk opens Indian R&D hub
Advertisement
Previous
2
Next